NeuVasQ is based on new insights into the molecular mechanisms maintaining the integrity of the blood-brain barrier (BBB). The BBB regulates the exchange between the vascular system and central nervous system (CNS). Increased BBB permeability, due to age or injury, is involved in many neurological conditions through the leakage of harmful blood substances into the CNS.
Medical, Pharmaceutical, Biotechnology
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as NeuVasQ? We’re happy to assist you with our Startup Sourcing service.